tetano
Editor, Senior Moderator
Curr Opin Immunol. 2018 Apr 19;53:51-57. doi: 10.1016/j.coi.2018.04.001. [Epub ahead of print]
[h=1]Development of next generation hemagglutinin-based broadly protective influenza virus vaccines.[/h] Nachbagauer R[SUP]1[/SUP], Palese P[SUP]2[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] Influenza viruses are a severe threat to human health and current vaccines do not provide sufficient protection. The highly variable nature of influenza viruses has made the production of efficacious vaccines a challenge. In recent years, a multitude of novel, broadly reactive influenza virus vaccination approaches have been described. What has long seemed impossible could now become reality in the near future-a new generation of influenza virus vaccines that provides long-lasting and broad protection against seasonal as well as potentially pandemic influenza virus strains. This review will discuss new hemagglutinin-based vaccines and their current stage of development.
PMID: 29680576 DOI: 10.1016/j.coi.2018.04.001
[h=1]Development of next generation hemagglutinin-based broadly protective influenza virus vaccines.[/h] Nachbagauer R[SUP]1[/SUP], Palese P[SUP]2[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] Influenza viruses are a severe threat to human health and current vaccines do not provide sufficient protection. The highly variable nature of influenza viruses has made the production of efficacious vaccines a challenge. In recent years, a multitude of novel, broadly reactive influenza virus vaccination approaches have been described. What has long seemed impossible could now become reality in the near future-a new generation of influenza virus vaccines that provides long-lasting and broad protection against seasonal as well as potentially pandemic influenza virus strains. This review will discuss new hemagglutinin-based vaccines and their current stage of development.
PMID: 29680576 DOI: 10.1016/j.coi.2018.04.001